AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 96,200 shares, a growth of 7.2% from the September 30th total of 89,700 shares. Based on an average daily volume of 29,200 shares, the short-interest ratio is currently 3.3 days. Currently, 2.7% of the shares of the stock are sold short.

AquaBounty Technologies Trading Down 2.8 %

Shares of AQB stock opened at $1.17 on Wednesday. AquaBounty Technologies has a 12-month low of $0.81 and a 12-month high of $4.03. The company has a market capitalization of $4.50 million, a P/E ratio of -0.14 and a beta of 1.15. The firm has a 50-day moving average price of $1.10 and a 200 day moving average price of $1.49. The company has a quick ratio of 1.96, a current ratio of 1.96 and a debt-to-equity ratio of 0.05.

AquaBounty Technologies (NASDAQ:AQB) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($1.56) earnings per share for the quarter, missing the consensus estimate of ($0.93) by ($0.63). The company had revenue of $0.18 million during the quarter, compared to analyst estimates of $0.10 million. AquaBounty Technologies had a negative net margin of 3,923.57% and a negative return on equity of 17.81%. Research analysts forecast that AquaBounty Technologies will post -4.86 earnings per share for the current fiscal year.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.